Beta Bionics, Inc./$BBNX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Beta Bionics, Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Ticker
$BBNX
Sector
Primary listing
Employees
422
Headquarters
Website
BBNX Metrics
BasicAdvanced
$482M
-
-$1.81
-
-
Price and volume
Market cap
$482M
52-week high
$32.71
52-week low
$8.89
Average daily volume
1.2M
Financial strength
Current ratio
8.663
Quick ratio
7.639
Long term debt to equity
1.865
Total debt to equity
2.539
Profitability
EBITDA (TTM)
-70.108
Gross margin (TTM)
55.40%
Net profit margin (TTM)
-73.02%
Operating margin (TTM)
-71.50%
Revenue per employee (TTM)
$240,000
Management effectiveness
Return on assets (TTM)
-18.73%
Return on equity (TTM)
-40.26%
Valuation
Price to revenue (TTM)
4.394
Price to book
1.68
Price to tangible book (TTM)
1.68
Price to free cash flow (TTM)
-7.836
Free cash flow yield (TTM)
-12.76%
Free cash flow per share (TTM)
-1.387
Growth
Revenue change (TTM)
53.94%
Earnings per share change (TTM)
-79.01%
3-year revenue growth (CAGR)
724.29%
3-year earnings per share growth (CAGR)
-48.15%
BBNX News
AllArticlesVideos
INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
Newsfile Corp·1 week ago
BBNX INVESTOR NOTICE: Faruqi & Faruqi, LLP Launches Investigation into Beta Bionics
Business Wire·2 weeks ago
BBNX INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
Newsfile Corp·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Beta Bionics, Inc. stock?
Beta Bionics, Inc. (BBNX) has a market cap of $482M as of March 17, 2026.
What is the P/E ratio for Beta Bionics, Inc. stock?
The price to earnings (P/E) ratio for Beta Bionics, Inc. (BBNX) stock is 0 as of March 17, 2026.
Does Beta Bionics, Inc. stock pay dividends?
No, Beta Bionics, Inc. (BBNX) stock does not pay dividends to its shareholders as of March 17, 2026.
When is the next Beta Bionics, Inc. dividend payment date?
Beta Bionics, Inc. (BBNX) stock does not pay dividends to its shareholders.
What is the beta indicator for Beta Bionics, Inc.?
Beta Bionics, Inc. (BBNX) does not currently have a Beta indicator.